news
News & Events
-
March 20, 2019 -
news
March 18, 2019 Almac Discovery Showcases its Deubiquitinase Drug Discovery Expertise at the American Association of Cancer Research Annual Meeting in Atlanta
Read more
-
news
August 6, 2018 VNAR Based Oncology Platform in development
Read more
-
news
July 5, 2018 Dr. Xavier Jacq Appointed Vice President, Biology
Read more
-
news
April 23, 2018 Latest developments in DUB inhibitors shared at Proteasome & Autophagy Congress
Read more
-
news
April 10, 2018 Almac Discovery to Present at AACR 2018
Read more
-
news
January 29, 2018 Research Highlighted in Nature Chemical Biology
Read more
-
news
December 4, 2017 USP7 inhibitors from UbiPlexTM Platform published
Read more
-
news
September 4, 2017 ALM201 Poster Presentation at 2017 ESMO Congress
Read more
-
news
July 3, 2017 ALM201 – Orphan Drug Designation Granted in Ovarian Cancer
Read more
-
news
June 20, 2017 Agreement with Debiopharm to Develop Novel Wee-1 Inhibitor
Read more
-
news
May 8, 2017 Wee-1 kinase patent approval granted
Read more
-
news
February 14, 2017 Therapy-resistant cancer tumors targeted with RCSI
Read more
-
news
May 30, 2016 Diseases of the eye explored with McClay Foundation and UU
Read more
-
news
February 4, 2016 Novel allosteric Akt inhibitor (ALM301) Patent Protection Secured
Read more
-
news
October 5, 2015 European Patent Protection for ALM201 Secured
Read more
-
news
July 10, 2015 Ubiquitin Specific Protease Collaboration with Genentech
Read more
-
news
September 4, 2013 £13m Investment Cancer Research Initiatives with QUB
Read more
-
news
April 27, 2009 Minister Praises Craigavon Life Sciences Firm’s Commitment to R&D
Read more
-
news
June 10, 2008 Almac Group Launches Oncology Discovery Arm
Read more